OpenAI recently confirmed that it has invested in its co-founder Sam Altman's Merge Labs, a brain computer interface startup.

LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

OpenAI has invested in Merge Labs, a brain-computer interface (BCI) startup co-founded by OpenAI CEO Sam Altman. The startup ...

Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...

A major step toward the industrialization of brain-computer interface technology was taken recently as NeuroXess, a Chinese ...

LumiMind, a next-generation neurotechnology company pioneering non-invasive, real-time neural modulation, will showcase ...

The INSIDE Institute for NeuroAI has shared new results that show brain-computer interface (BCI) technology is now being used ...

Signal Enhancement: An acoustic-driven signal enhancement approach based on NeRF acoustic field modeling and nested generative networks supplements missing or incomplete EEG data through acoustic ...

Merge Labs is a “research lab” dedicated to “bridging biological and artificial intelligence to maximize human ability.” ...

The man is enrolled in the BrainGate2 clinical trial at UC Davis Health. His ability to communicate through a computer has ...

Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego Synchron, a leader in non-surgical brain-computer interface ...